PPAR- agonists: therapeutic role in diabetes, inflammation and cancer

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.12, 2000-12, pp. : 469-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Measuring biomarkers to assess the therapeutic effects of PPAR agonists?

By Chinetti-Gbaguidi Giulia Staels Bart

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1567-1580

Future Medicine

Access to resources Recommend Favorite

PPAR-&ggr; Agonists as Regulators of Microglial Activation and Brain Inflammation

Current Pharmaceutical Design, Vol. 12, Iss. 1, 2006-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

New Pharmacological Perspectives and Therapeutic Potential of PPAR-&ggr; Agonists

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3505-3524

Bentham Science Publishers

Access to resources Recommend Favorite

The Current Role and Therapeutic Targets of Vitamin D in Gastrointestinal Inflammation and Cancer

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2917-2923

Bentham Science Publishers

Access to resources Recommend Favorite

Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 636-649

Bentham Science Publishers

Access to resources Recommend Favorite